Product Description
Daruvir 600 (Darunavir 600mg Tablets) harnesses the latest advancements in antiretroviral therapy. Capitalise on Cipla Ltd.'s masterful pharmaceutical expertise with this laureate solution for HIV-1 infection in adults and adolescents. This lofty, affordable treatment features Darunavir, a potent protease inhibitor, ensuring reliable efficacy in combination regimens. Each bottle contains 60 white tablets, suitable for oral administration. As a Schedule H prescription medicine, Daruvir 600 requires physician oversight. Store tightly closed below 30C to protect from light and moisture, and always keep out of reach of children.
Daruvir 600: Distinctive Advantages and Applications
Daruvir 600 stands out for its competitive advantages, including its masterful formulation, proven efficacy as a protease inhibitor, and suitability for both adults and adolescents with HIV-1 infection. Produced by Cipla Ltd., it carries laureate quality standards, ensuring consistency and safety. The product is recommended for use alongside other antiretrovirals, providing advanced management of HIV-1. Its oral tablet form is convenient, making it a preferred choice for healthcare professionals and patients alike.
Packaging, Export Strategy & Sample Policy for Daruvir 600
Daruvir 600 is supplied in a tightly sealed bottle containing 60 tablets per pack. The proposal amount and expenditure for bulk purchases align with its high market value in global healthcare markets. As an esteemed exporter, supplier, and trader from India, Cipla Ltd. covers diverse international markets. Sample provisions are available upon negotiation, enabling partners to align with their market requirements and assess product suitability for their target demographics.
FAQ's of Daruvir 600 (Darunavir 600mg Tablets):
Q: How should Daruvir 600 (Darunavir 600mg Tablets) be taken for optimal effectiveness?
A: Daruvir 600 should be administered orally with food, as directed by your physician. Strictly adhere to your prescribed dosage and schedule for the best therapeutic outcome.
Q: What distinguishes Daruvir 600 from other antiretroviral medications?
A: Daruvir 600 contains the latest laureate formulation of Darunavir, a masterful protease inhibitor. It is renowned for its efficacy when used with other antiretroviral agents, providing reliable management for HIV-1 infection.
Q: When should Daruvir 600 be stored and handled with care?
A: Always store Daruvir 600 tightly closed, below 30C, and protected from moisture and light. Keep it out of reach of children and only use it as prescribed by a healthcare professional.
Q: Where is Daruvir 600 manufactured and by whom?
A: Daruvir 600 is manufactured and marketed by Cipla Ltd. in India, a leading name known for its commitment to pharmaceutical innovation.
Q: What is the process for obtaining Daruvir 600?
A: As a Schedule H prescription-only medication, Daruvir 600 can be obtained through a licensed pharmacy with a valid doctor's prescription. Consult your healthcare provider to begin therapy.
Q: What are the main benefits of using Daruvir 600 for HIV-1 infection?
A: Daruvir 600 offers affordable, high-standard antiretroviral therapy. Its unique formulation and proven effectiveness help control HIV-1 infection and support improved quality of life when used as part of a combination regimen.